These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25499288)

  • 1. FOLFOXIRI and bevacizumab in metastatic colorectal cancer.
    Rahman A
    Lancet Oncol; 2014 Dec; 15(13):e590. PubMed ID: 25499288
    [No Abstract]   [Full Text] [Related]  

  • 2. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
    Nipp RD; Ryan DP
    Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
    Loupakis F; Cremolini C; Masi G; Lonardi S; Zagonel V; Salvatore L; Cortesi E; Tomasello G; Ronzoni M; Spadi R; Zaniboni A; Tonini G; Buonadonna A; Amoroso D; Chiara S; Carlomagno C; Boni C; Allegrini G; Boni L; Falcone A
    N Engl J Med; 2014 Oct; 371(17):1609-18. PubMed ID: 25337750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab or bevacizumab in metastatic colorectal cancer?
    Sclafani F; Cunningham D
    Lancet Oncol; 2014 Sep; 15(10):1040-1. PubMed ID: 25088941
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the treatment of metastatic colorectal cancer with bevacizumab].
    Longo F; Mansueto G
    Tumori; 2006; 92(5):suppl 1-12. PubMed ID: 17168449
    [No Abstract]   [Full Text] [Related]  

  • 6. [A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].
    Kawakami H; Satoh T; Nakagawa K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():439-45. PubMed ID: 22214001
    [No Abstract]   [Full Text] [Related]  

  • 7. Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis.
    Shui L; Wu YS; Lin H; Shui P; Sun Q; Chen X
    Cell Physiol Biochem; 2018; 48(5):1870-1881. PubMed ID: 30092572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy for metastatic colorectal cancer.
    Giampieri R; Cascinu S
    Lancet Oncol; 2015 Oct; 16(13):1281-2. PubMed ID: 26361970
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance treatment in metastatic colorectal cancer.
    Simkens LH; van Tinteren H; Punt CJ; Koopman M
    Lancet Oncol; 2015 Dec; 16(16):e582-3. PubMed ID: 26678201
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance treatment in metastatic colorectal cancer.
    Chibaudel B; Bonnetain F; Tournigand C; de Gramont A
    Lancet Oncol; 2015 Dec; 16(16):e583-4. PubMed ID: 26678202
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy for metastatic colorectal cancer.
    Rosales J; Leong LA
    J Natl Compr Canc Netw; 2005 Jul; 3(4):525-9. PubMed ID: 16038643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802).
    Aparicio T; Linot B; Le Malicot K; Bouché O; Boige V; François E; Ghiringhelli F; Legoux JL; Ben Abdelghani M; Phelip JM; Faroux R; Dahan L; Taieb J; Bedenne L
    Dig Liver Dis; 2015 Apr; 47(4):271-2. PubMed ID: 25677925
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of bevacizumab in Chinese patients with metastatic colorectal cancer.
    Zhu LM; Zhao YZ; Ju HX; Liu LY; Chen L; Liu BX; Xu Q; Luo C; Ying JE; Yang YS; Zhong HJ
    Asian Pac J Cancer Prev; 2014; 15(16):6559-64. PubMed ID: 25169487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOLFOXIRI in metastatic colorectal cancer: A criticism from its native land.
    Ottaiano A; Nasti G; Cassata A; De Stefano A; Caraglia M; Avallone A
    Cancer Lett; 2017 Nov; 408():71-72. PubMed ID: 28844712
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintenance treatment in metastatic colorectal cancer - Authors' reply.
    Hegewisch-Becker S; Graeven U; Arnold D
    Lancet Oncol; 2015 Dec; 16(16):e584-5. PubMed ID: 26678203
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients.
    Formica V; Massara MC; Portarena I; Fiaschetti V; Grenga I; Del Vecchio Blanco G; Sileri P; Tosetto L; Skoulidis F; Pallone F; Roselli M
    Cancer Biomark; 2009; 5(4):167-75. PubMed ID: 19729826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents.
    Cetin B; Kaplan MA; Berk V; Ozturk SC; Benekli M; Isıkdogan A; Ozkan M; Coskun U; Buyukberber S
    Asian Pac J Cancer Prev; 2012; 13(3):1059-63. PubMed ID: 22631638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer.
    Park LC; Lee HS; Shin SH; Park SJ; Park MI; Oh SY; Kwon HC; Baek JH; Choi YJ; Kang MJ; Kim YS
    World J Gastroenterol; 2012 Mar; 18(10):1104-9. PubMed ID: 22416186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical removal of metastases after successful treatment containing bevacizumab in metastatic colorectal cancer.
    Afonso S; Viani G; Afonso V; Stefano E; Afonso S
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S21-3. PubMed ID: 21768794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
    Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
    Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.